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Abstract We studied changes in secondary metabolites in 
human neutrophils undergoing constitutive or tumour necrosis 
factor (TNFa) stimulated apoptosis by a combination of high- 
performance liquid chromatography (HPLC) and NMR 
spectroscopy. Our results show that in contrast to freshly 
isolated neutrophils, neutrophil cells aged for 20 h in vitro had 
marked differences in the levels of a number of endogenous 
metabolites including lactate, amino acids and phosphocholine 
(PCho). There was no change in the concentration of taurine or 
glutamate and the ATP/ADP ratio was not affected. Levels of 
glutamine and lactate actually decreased. Identical changes were 
also observed in neutrophils timulated to undergo apoptosis over 
a shorter time period (6 h) in the presence of TNFct and the 
phosphatidylinositol-3-kinase inhibitor wortmannin (WM). The 
changes in the concentration of PCho suggest possible activation 
of phosphoHpase associated with apoptosis or a selective failure 
of phosphatidycholine synthesis. The increased levels of apoptosis 
obtained with WM+TNFcz, compared to TNFtz by itself, suggest 
a synergistic effect by these compounds. The acceleration in rate 
of apoptosis probably arises from suppression by WM of 
pathway(s) that normally delay the onset of apoptusis. Changes 
in PCho and other endogenous metabolites, if proven to be 
characteristic of apoptosis in other cell systems, may permit non- 
invasive quantification of apoptosis. 
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1. Introduction 
Apoptosis is vital in many normal cellular processes, involv- 
ing embryonic development, clonal selection of cells in the 
immune system, control of viral infection and the deletion 
of cancer cells [1]. Once initiated, programmed cell death is 
rapid and results in a cell which retains membrane integrity, 
but has become recognisable to and can be phagocytosed by 
other cells by a process that does not incite an inflammatory 
response [2,3]. Although there are many morphological 
changes, such as nuclear condensation, membrane ruffling 
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and vacuolisation of the cytoplasm [4], which are character- 
istic accompaniments of apoptosis, many organelles, such as 
the mitochondria, remain intact [5]. These factors indicate not 
a generalised failure of cellular metabolism, but an active 
programmed pathway designed to ensure that the damaged 
or unwanted cell is removed intact by phagocytosis. Since 
the functional and morphological endpoint in many cells un- 
dergoing apoptosis is the same, it is possible that many of the 
final effector pathways are similar, regardless of how they may 
be initiated. While much progress has been made on under- 
standing the genetic ontrols of apoptosis, little is understood 
about the effector metabolic pathways involved. Although 
some signalling proteins have been implicated in the control 
of apoptosis, such as the mitogen activated protein (MAP) 
kinase, sphingomyelin-ceramide and protein kinase C 
(PKC)[1], their precise role remains uncertain. Defining the 
precise metabolic hanges associated with apoptosis may al- 
low important insights into these processes and permit devel- 
opment of methods to monitor such changes in vivo. 
Neutrophils in culture undergo rapid and constitutive apop- 
tosis (up to 80% apoptosis within 24 h). The morphological 
and molecular changes associated with this process have been 
fully characterised [2] and the endogenous rate of apoptosis of 
neutrophils can be modulated by various cytokines [6,7]. Neu- 
trophil apoptosis has also been observed in vivo, where it is 
considered to represent a major physiological mechanism un- 
derlying the clearance of these cells from a site of inflamma- 
tion [8]. This makes the neutrophil an ideal model to deter- 
mine the secondary metabolic changes associated with 
apoptosis. In this study, we have used a combination of 
NMR spectroscopy and HPLC to determine changes in sec- 
ondary metabolites associated with apoptosis. 
2. Materials and methods 
2.1. Reagents 
Wortmannin and TNFct were obtained from ICN Pharmaceutical 
(UK). All other chemicals were of the highest purity commercially 
available. 
2.2. Cell culture and apoptosis 
Fresh neutrophils were prepared from 200 ml citrate-treated blood, 
taken from healthy volunteers, by dextran sedimentation and percoll 
gradients [2]. Naturally apoptotic eils were prepared by incubation 
overnight at 10 × 108 cellsdml in 10% autologous serum/Ischoves mod- 
ified Dulbecco's medium until 70% apoptotic (between 20 and 26 h). 
Percentage apoptosis was determined by counting cells after cytospin- 
ning and two-step Difquick staining. Apoptotic ells were defined as 
having more than one darkly stained pyknotic nucleus. Membrane 
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integrity was determined by trypan blue exclusion. Cells for experi- 
ments in which apoptosis was induced or inhibited, were counted and 
harvested at 6 h. Because of wortmannin's labile nature, it was added 
initially at 100 nM and then topped up at hourly intervals with further 
50 nM aliquots. TNFct was added at 12.5 ng/ml. 
For NMR spectroscopy, between 60 and 200×106 cells were 
washed three times in PBS and then extracted in 1-2 ml ice-cold 
12% PCA, sonicated 2×30 s, spun at 10000×g 2 min and the pellet 
kept for protein determination. The pH of the supernatant was then 
adjusted to 7.4 with KOH, the alkaline supernatant was respun at 
10000×g for 2 min to remove any precipitated KC104 and lyophi- 
lised for storage at -20°C. The lyophilized cell extract was redissolved 
in 0.6 ml D20 and 10 Ixl TSP and the pH readjusted to 7.4 with DCI 
or NaOD. 
2.3. NMR and HPLC methods 
NMR spectroscopy of extracts was performed at 11.7 T (JEOL) at 
21°C. Fully relaxed spectra were acquired with a 45 ° pulse, 16 K data 
points, 1024 scans. An internal standard, TSP (3-trimethylsilyl-pro- 
pionic-2,2,3,3-d4 acid, Aldrich Chemical Co, UK), was added as a 
chemical shift and absolute quantitation reference. Signal assignment 
was carried out as described by Sze and Jardetzky [9], using a combi- 
nation of chemical shift information, multi-dimensional NMR and 
samples piking with pure compounds. Amino acid content of cell 
extracts was measured by HPLC [10]. Essential amino acids were 
analysed by derivatisation with o-phthaldialdehyde (OPA) and the 
concentrations were calculated from external standards. A LiChro- 
Graph HPLC system (Merck-Hitachi, Darmstadt, Germany) 
equipped with a LiChroGraph 100HP-18 separation column (5 mm; 
4 mm i.d., 25 cm length) was used. The OPA derivatives were detected 
with an UV/VIS fluorometer (LiChroGraph F1050), characterised by 
the l'ollowing wavelengths: excitation, 340 nm; emission, 450 nm. 
Aliquots taken from NMR samples were diluted 10-100-fold with 
ultrapure water, and 150-250 ml sample was mixed with 350 ml re- 
agent containing 0.8 mg/ml OPA (Sigma). The compounds were al- 
lowed to react for 3 min. Then 150 ml mixture was injected onto the 
column. Elution was achieved at 40°C with a three-step linear gradi- 
ent of methanol in phosphate buffer (50 mmol/1 in ultrapure water, 
pH 6) starting at 20% methanol, increasing to 35% methanol in 5 min, 
then decreasing to 30% methanol in 30 min and finishing at 35 min 
with 20% methanol. 
Protein content was determined using the BioRad reagent kit 
(BioRad, Watford, Herts, UK) and BSA standards as reference pro- 
teins. 
3. Results and discussion 
In this study we have shown, by a combinat ion of NMR 
spectroscopy and HPLC, significant differences in the meta- 
bolic profile of extracts from non-apoptot ic and apoptotic 
neutrophils. These include alterations in membrane-associated 
components, amino acids and intermediary metabolites. Typi- 
Table 1 
Metabolite concentration i fresh and apoptotic neutrophil extracts 
assessed by NMR and HPLC (nmol]mg protein) 
Non-Apoptotic Apoptotic ~
Phosphocholine 4.0 + 2.3 11.1 _+ 3.7 b 
Lactate 46.2 + 14 20.6 + 9.0 b 
Glutamine 58.8 + 27 26.5 + 12 c 
Tyrosine 0.7 + 0.2 1.6 + 0.3 ~ 
Serine 10.8 + 3.9 18.7 + 6.9 ° 
Choline 1.5 + 1.2 3.4 + 1.6 
Arginine 21.1 + 13 37.3 + 21 
Glycine 28.6 + 7.3 21.4 + 10 
Taurine 198+ 25 186+ 33 
H-taurine 3.5 + 1.5 1.9 + 1.1 
Alanine 17.7 + 8.2 14.8 + 6.4 
Aspartate 39.7 + 14 46.6 + 27 
Glutamate 62.1 + 16 65.5 + 25 
aCell underwent constitutive apoptosis in culture (see Section 2). 
bp<0.01 and Cp<0.05. 
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Fig. 1. High resolution 1H-NMR spectra from perchloric acid ex- 
tracts on (a) non-apoptotic and (b) apoptotic neutrophils. Reso- 
nances from a variety of metabolites can be readily observed includ- 
ing lactate (Lac), acetate (A), ghitamine and glutamate (Glx), 
choline, phosphocholine and glycerophosphocholine (Cho), taurine 
(Tau), glycine (Gly), nucleotide tri/diphosphates (NTP+NDP). 
cal tH -NMR spectra from perchloric acid extracts of non- 
apoptotic neutrophils are shown in Fig. la. Resonances 
from a variety of metabolites could be readily observed in- 
cluding lactate, acetate, amino acids, taurine, glycerophospho- 
choline, PCho, choline and nucleotide phosphates. Spectra 
from apoptotic neutrophils (Fig. lb) showed that the concen- 
tration of some of these metabolites were significantly altered. 
PCho was greatly increased (Fig. 2), while the concentrat ion 
of glutamine and lactate showed a marked decrease. Increased 
levels of tyrosine and other aromatic amino acids were also 
observed. The concentrat ion of the other metabolites ana- 
lysed, including taurine, glutamate and the ATP/ADP ratio, 
showed no significant differences between the apoptotic and 
non-apoptot ic ells. A summary of the results is shown in 
Table 1. 
The ATP/ADP ratio of apoptotic neutrophil  extracts 
(1.08 + 0.47) as determined by NMR was similar to those of 
non-apoptot ic ell extracts (1.31+0.28), implying that they 
were still capable of energy production. This supports obser- 
vations by Wallen et al. [11] that apoptosis may be energy 
dependent. Previously published work suggests that mitochon- 
drial function may be compromised uring apoptosis, possibly 
affecting oxidative phosphorylat ion [1,12]. I f  this were correct, 
cells undergoing apoptosis would rely on increased anaerobic 
respiration to maintain normal energy levels. This would in 
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Fig. 2. High resolution IH-NMR spectra (expansion: 3.00-3.70 
ppm) from perchloric acid extracts of non-apoptotic and apoptotic 
neutrophils. Resonance assignment: Gly, glycine; Tau, taurine; 
PCho, phosphocholine. There was a marked increase in the concen- 
tration of PCho in apoptotic ells compared to controls. 
turn lead to increased lactate production. In this study how- 
ever, we have observed a significant fall in lactate concentra- 
tion in apoptotic ells (control: 46.2 + 14 nmol/mg protein vs 
apoptotic: 20.6 + 9 nmol/mg protein; p < 0.01), arising from 
either a decrease in lactate output and/or an increase in lactate 
metabolism. Maretzek et al. [13] have similarly shown an 
apoptosis-related decrease in lactate concentration, together 
with reduction in glucose consumption and glycogen synthesis 
in T47D spheroids. This suggests that decreased lactate levels 
may be a common factor in apoptotic ells and may further 
differentiate them from necrotic ells. The stage at which the 
lactate begins to decline during apoptosis remains to be de- 
termined, but once initiated, the energy for apoptosis may be 
derived from alternative fuel molecules uch as lactate and 
glutamine. Indeed, the redox potential of the cell can affect 
gene transcription, as well as altering the response to certain 
signalling molecules possibly through NF-~cB [14]. It is there- 
fore of interest hat TNFct can activate the transcriptional 
regulator NF-~B, possibly via the generation of reactive oxy- 
gen intermediates (ROI) [14] and that apoptosis can be in- 
duced independently by oxidative damage [15]. Agents which 
increase levels of glutathione can inhibit the formation of ROI 
and suppress apoptosis and NF-KB activity [14,15]. Hence, the 
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redox status of the cell and apoptosis appear to be intimately 
linked and changes in lactate and other compounds, such as 
glutamine, may be indicative of energetic changes in the apop- 
totic process. 
The increase in the aromatic amino acid tyrosine was un- 
expected (Table 1), but could be due to a number of reasons, 
including protein degradation, a selective Tyr dephosphoryla- 
tion of proteins or inward leakage through the plasma mem- 
brane from the support medium. Alteration in the cell mem- 
brane associated with apoptosis could lead to an increase in 
porosity [16]. However, the similarity in levels of taurine and 
many aliphatic amino acids between apoptotic and non-apop- 
totic cells and the ability of apoptotic neutrophils to exclude 
trypan blue are consistent with an intact membrane. There- 
fore, the increase in aromatic amino acids might reflect the 
cleavage of specific aromatic rich peptides, such as membrane 
targeting sequences, by proteases which are known to be in- 
volved in apoptosis [17]. 
The increase in the concentration of PCho in apoptotic 
neutrophils is of special interest since this molecule is gener- 
ated following the activation of a phosphatidylcholine-specific 
phospholipase D (PLD) or phospholipase C (PLC). These 
pathways have been linked to the induction of apoptosis in 
other cell models. The increased PCho concentration i apop- 
totic neutrophil extracts is unlikely to derive from new mem- 
brane synthesis because of the differentiated state of the neu- 
trophil. However, in many cells, phosphatidylcholine 
(PtdCho) hydrolysis is elicited by a variety of growth factors, 
cytokines and neuropeptides hormones [18] and leads to an 
increase in diacylglycerol (DAG), and phosphocholine (PLC- 
mediated hydrolysis) or phosphatidic acid and choline (PLD- 
mediated hydrolysis) [19]. While neutrophils do not possess 
PtdCho active PLC [20], the PLD generated phosphatidic 
acid can be readily converted to DAG by a phosphatidate 
phosphohydrolase. DAG mediated activation of PKC has 
been implicated in growth regulation and protection from 
apoptosis [21]. In the neutrophil, activation of phospholipase 
D [22] or PKC results in upregulation of its anti-bacterial 
capabilities and suppression of apoptosis [6]. To ascertain 
whether increased PLD-mediated PtdCho hydrolysis could 
be implicated in the increased levels of PCho detected, neu- 
trophil incubations were performed in the presence of Wort- 
mannin (WM) in addition to TNFc~ which as well as inhibit- 
ing P13K activity also inhibits PLD activity in these cells 
[23,24]. 
Wortmannin by itself had very little effect on apoptotic 
rates at 6 h (WM: 2.6+1.2 vs control: 1.6+0.36%, n=3, 
p < 0.5). TNFtx alone gave a significant increase in the rate 
of apoptosis (TNFtx: 7.4+3.9 vs control: 1.7+0.9%, n=3, 
p < 0.005). When wortmannin was combined with TNFc~, a 
large increase in apoptosis at 6 h was observed (TNFct+WM: 
40.6 + 3.4% vs control: 1.6 + 0.36%, n = 3, p < 0.005). This in- 
creased rate may possibly be due to a removal of a protective 
effect of phosphoinositol 3,4,5-triphosphate (PIP3) on apop- 
tosis [25]. Under these conditions, in which PLD activity is 
significantly attenuated [22], preliminary 1H-NMR spectra 
still show an increased PCho signal (6.30+ 2.1 nmol/mg pro- 
tein) in TNFtx+WM treated cells at 6 h, compared to control 
or WM treated cells alone. This would indicate that the PCho 
signals are unlikely to be linked to the activation of a PtdCho- 
directed phospholipase. 
In many cells, TNFct is thought o induce apoptosis by the 
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release of ceramide through the activation of sphingomyeli- 
nase [21]. This reaction also releases PCho, and hence may be 
an alternative source for the increase in this compound. This 
hypothesis i supported by the observation that ceramide itself 
can induce apoptosis in many cells as well as inhibiting DNA 
synthesis [26,27]. Although ceramide does not induce apopto- 
sis in neutrophils, its catabolite, sphingosine, is a potent apop- 
totic agent [21]. One of the ways in which sphingosine is 
thought to promote apoptosis is by inhibiting PKC activity 
[27]. Therefore, in the neutrophil, activation of the sphingo- 
myelinase pathway as an initiating event, or as a consequence 
of apoptosis, is certainly a potential route for the generation 
of PCho. 
In conclusion, we have shown that it is possible to study 
changes in secondary metabolism associated with apoptosis. 
In our study, the inability of wortmannin to attenuate the 
increase in PCho observed with both constitutive and TNFa  
induced apoptosis uggests a source other than stimulation of 
PtdCho-directed PLD activity, possibly via the breakdown of 
ceramide [22]. Furthermore, we have seen changes in lactate 
and other metabolites. When taken together, these changes 
may uniquely characterise cells undergoing apoptosis. If simi- 
lar findings are apparent in other apoptotic ells, then it may 
be possible to define a metabolite fingerprint characteristic of
this process, akin to the defining morphological features of 
apoptosis. Such observations might make it possible to use 
NMR for non-invasive quantification of apoptosis in cell cul- 
ture and possibly in pathology, e.g. during chemotherapy of
tumour masses. 
Acknowledgements: This work was supported by the Medical Re- 
search Council. We would also like to thank the University of London 
Intercollege Research Services (ULIRS) at Birkbeck College for use of 
their NMR facilities. M.L.B. is in receipt of a Wellcome Trust Ad- 
vance Training Fellowship. 
References 
[I] Evans, V.G. (1993) Cell Biol. Int. 17, 461476. 
[2] Savill, J.S., Wyllie, A.H., Henson, J.E., Walport, M.J., Henson, 
P.M. and Haslett, C. (1989) J. Clin. Invest. 83, 865-875. 
[3] SaviU, J.S. (1992) Clin. Sci. 83, 649-655. 
[4] Ellis, R.E., Yuan, J. and Horvitz, H.R. (1991) Annu. Rev. Cell 
Biol. 7, 663-698. 
[5] Wolvetang, E.J., Johnson, K.L., Krauer, K., Ralph, S.J. and 
Linnane, A.W. (1994) FEBS Lett. 339, 40~4. 
[6] Lee, A., Whyte, M. and Haslett, C. (1993) J. Leukoc. Biol. 54, 
283-288. 
[7] Takeda, Y., Watanabe, H., Yonehara, S., Yamashita, T., Saito, 
S. and Sendo, F. (1993) Int. Immunol. 5, 691~94. 
[8] Grigg, J.M., Savill, J.S., Sarraf, C., Haslett, C., Silverman, M. 
(1991) Lancet 338, 720-722. 
[9] Sze, D.Y. and Jardetzky, O. (1990) Biochim. Biophys. Acta 1054, 
181-197. 
[10] Lindroth, P. and Mopper, K (1979) Anal. Chem. 51, 1667-1674. 
[11] Wallen, O.M., Lonnbro, P., Schon, A. and Borrebaeck, C.A. 
(1993) Cancer Lett. 75, 103-109. 
[12] Vayssiere, J.C., Petit, P.X., Risler, Y. and Mignotte, B. (1994) 
Proc. Natl. Acad. Sci. USA 91, 11752-11756. 
[13] Maretzek, A.F., Haran, F., Goldberg, I., Horowitz, A. and De- 
gani, H. (1994) Abstract, Society of Magnetic Resonance, San 
Francisco, CA. 
[14] Shibanuma, M., Kuroki, T. and Nose, K. (1994) FEBS Lett. 353, 
62-66. 
[15] Sandstrom, P.A., Mannie, M.D. and Buttke, T.M. (1994) J. Leu. 
Biol. 55, 221-226. 
[16] Mower, D.A., Peckham, D.W., Illera, V.A., Fishbaugh, J.K., 
Stunz, L.L. and Ashman, R.F. (1994) J. Immunol. 152, 483~ 
4842. 
[17] Yuan, J., Shaham, S., Ledoux, S., Ellis, H.M. and Horvitz, H.R. 
(1993) Cell 75, 641-52. 
[18] Exton, J.H. (1994) Biochim. Biophys. Acta 1212, 26~2. 
[19] Majerus, P.W. (1992) Annu. Rev. Biochem. 61,225-50. 
[20] Strum, J.C., Nixon, A.B., Daniel, L.W., Wykle, R.L. (1993) Bio- 
chim. Biophys. Acta 1169, 25-29. 
[21] Hannun, Y.A. and Obeid, L.M. (1995) Trends Biochem. Sci. 20, 
73-77. 
[22] Bonser, R.W., Thompson, N.T., Randall, R.W. and Garland, 
L.G. (1989) Biochem. J. 264, 617q520. 
[23] Thelen, M., Wymann, M.P. and Langen, H. (1994) Proc. Natl. 
Acad. Sci. USA 91, 4960-4964. 
[24] Ohta, H., Yatomi, Y., Sweeny, E.A., Hakomori, S. and Igarashi, 
Y. (1994) FEBS Lett. 355, 267-270. 
[25] Yao, R. and Cooper, G.M. (1995) Science 267, 2003-2006. 
[26] Gomez-Munoz, A., Martin, A., O'Brien D. and Brindley D.N. 
(1994) J. Cell Biol. 269, 8937-8943. 
[27] Bauldry, S.A., Bass, D.A., Cousart, S.L. and McCall, C.E. (1991) 
J. Cell Biol. 266, 4173~1179. 
